Rice Bran Arabinoxylan Compound and Quality of Life (RBAC-QoL) of Cancer Patients: An Interim Analysis of the RBAC-QoL Study.

Cureus · 2024 · PMC10901676 · PMID 38425632

Europe PMC DOI

hedged sentence

0.0690

closest p · 1.4× alpha

0.0690

boldest claim

The sentences

marginally significantp = 0.069so close (0.05 < p ≤ 0.1)

The mean QL2 difference between RBAC and placebo at Visit 2 (Week 12) was also marginally significant (79.77 ± 4.81 vs. 67.86 ± 10.13, p = 0.069, Cohen’s d = 1.427).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.